A. Prové

1.8k total citations
32 papers, 1.4k citations indexed

About

A. Prové is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, A. Prové has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 13 papers in Cancer Research and 8 papers in Molecular Biology. Recurrent topics in A. Prové's work include Cancer Treatment and Pharmacology (11 papers), Cancer Cells and Metastasis (6 papers) and Breast Cancer Treatment Studies (5 papers). A. Prové is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Cancer Cells and Metastasis (6 papers) and Breast Cancer Treatment Studies (5 papers). A. Prové collaborates with scholars based in Belgium, Norway and Netherlands. A. Prové's co-authors include Luc Dirix, Ina Benoy, D. Schrijvers, Peter A. van Dam, P. Vermeulen, M. Martin, Christel De Pooter, Adam Pawinski, P. Huget and A. van Oosterom and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

A. Prové

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Prové Belgium 16 742 408 384 310 129 32 1.4k
Paola Papaldo Italy 25 1.1k 1.5× 411 1.0× 439 1.1× 336 1.1× 93 0.7× 66 1.7k
K. Syrigos Greece 23 1.1k 1.5× 388 1.0× 288 0.8× 638 2.1× 120 0.9× 73 1.9k
F. Ries Luxembourg 21 622 0.8× 330 0.8× 256 0.7× 325 1.0× 323 2.5× 70 1.7k
Cecilia Nisticò Italy 23 1.2k 1.6× 306 0.8× 555 1.4× 403 1.3× 100 0.8× 70 1.6k
Giuseppe Fraschini United States 23 1.4k 1.9× 268 0.7× 933 2.4× 319 1.0× 428 3.3× 53 2.1k
Michel Marty France 23 1.8k 2.5× 542 1.3× 743 1.9× 487 1.6× 242 1.9× 47 3.0k
G. Deplanque France 23 1.3k 1.7× 633 1.6× 542 1.4× 812 2.6× 166 1.3× 77 2.3k
Paul Stonelake United Kingdom 20 433 0.6× 526 1.3× 369 1.0× 218 0.7× 111 0.9× 40 1.5k
Yang Yao China 29 1.2k 1.6× 694 1.7× 302 0.8× 1.1k 3.5× 207 1.6× 125 2.4k
Nobuyuki Mizunuma Japan 23 1.5k 2.0× 506 1.2× 367 1.0× 530 1.7× 231 1.8× 133 2.0k

Countries citing papers authored by A. Prové

Since Specialization
Citations

This map shows the geographic impact of A. Prové's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Prové with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Prové more than expected).

Fields of papers citing papers by A. Prové

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Prové. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Prové. The network helps show where A. Prové may publish in the future.

Co-authorship network of co-authors of A. Prové

This figure shows the co-authorship network connecting the top 25 collaborators of A. Prové. A scholar is included among the top collaborators of A. Prové based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Prové. A. Prové is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dirix, Luc, Dieter Peeters, A. Prové, et al.. (2022). Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer. Breast Cancer Research and Treatment. 193(2). 437–444. 33 indexed citations
2.
Dirix, Luc, et al.. (2022). Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer. Breast Cancer Research and Treatment. 192(3). 583–591. 10 indexed citations
3.
Prové, A. & Luc Dirix. (2016). Neratinib for the treatment of breast cancer. Expert Opinion on Pharmacotherapy. 17(16). 2243–2248. 9 indexed citations
4.
Peeters, Dieter, Gert G. Van den Eynden, Pieter‐Jan van Dam, et al.. (2011). Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer. British Journal of Cancer. 104(9). 1472–1477. 30 indexed citations
5.
Trinh, Xuan Bich, Steven Van Laere, A. Prové, et al.. (2011). A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.. Journal of Clinical Oncology. 29(15_suppl). e11072–e11072. 25 indexed citations
6.
Dirix, Luc, Peter A. van Dam, A. Prové, & P Vermeulen. (2010). Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?. Therapeutic Advances in Medical Oncology. 2(5). 331–342. 4 indexed citations
7.
Auwera, Ilse Van der, Dieter Peeters, Ina Benoy, et al.. (2009). Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT–PCR in patients with metastatic breast cancer. British Journal of Cancer. 102(2). 276–284. 145 indexed citations
8.
Dirix, Luc, Patrick Neven, A. Prové, et al.. (2008). Delivery of adjuvant sequential dose-dense FEC–Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment sequence. Breast Cancer Research and Treatment. 114(1). 103–112. 22 indexed citations
9.
Paridaens, Robert, Luc Dirix, Herlinde Dumez, et al.. (2007). Phase I/II Pharmacokinetic Study of Pemetrexed and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer. Clinical Breast Cancer. 7(11). 861–866. 5 indexed citations
10.
Dirix, Luc, Peter A. van Dam, A. Prové, & Peter Vermeulen. (2006). Inflammatory breast cancer: current understanding. Current Opinion in Oncology. 18(6). 563–571. 28 indexed citations
11.
Dirix, Luc, Roberto Salgado, Reinhilde Weytjens, et al.. (2002). Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. British Journal of Cancer. 86(3). 389–395. 165 indexed citations
12.
Vos, Filip De, et al.. (2000). Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. British Journal of Cancer. 82(2). 291–294. 169 indexed citations
13.
Kvinnsland, Stener, Gun Anker, Luc Dirix, et al.. (2000). High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment. European Journal of Cancer. 36(8). 976–982. 50 indexed citations
14.
Vermeulen, P., Adam Pawinski, A. Prové, et al.. (1997). Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. British Journal of Cancer. 76(2). 238–243. 253 indexed citations
15.
Hoof, Viviane Van, M. De Martin, P. Blockx, et al.. (1995). Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serum. Clinical Chemistry. 41(6). 853–857. 11 indexed citations
16.
Dirix, Luc, G. Catimel, A. Prové, et al.. (1995). Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149. Anti-Cancer Drugs. 6(1). 53–63. 13 indexed citations
17.
Huinink, W.W. ten Bokkel, A. Prové, Martine Piccart, et al.. (1994). A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancer. Annals of Oncology. 5(6). 527–532. 117 indexed citations
18.
Schrijvers, D., J. Wanders, Luc Dirix, et al.. (1993). Coping with toxicities of docetaxel (TaxotereTM). Annals of Oncology. 4(7). 610–611. 123 indexed citations
19.
Dirix, Luc, A. Prové, D. Becquart, et al.. (1991). Tumor lysis syndrome in a patient with metastatic merkel cell carcinoma. Cancer. 67(8). 2207–2210. 41 indexed citations
20.
Demey, Hendrik E., Jan P. van Meerbeeck, M. Vandewoude, et al.. (1989). Respiratory Insufficiency in Acid Maltase Deficiency: The Effect of High Protein Diet. Journal of Parenteral and Enteral Nutrition. 13(3). 321–323. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Papaldo Breakdown of academic impact, for papers by K. Syrigos Breakdown of academic impact, for papers by F. Ries Breakdown of academic impact, for papers by Cecilia Nisticò Breakdown of academic impact, for papers by Giuseppe Fraschini Breakdown of academic impact, for papers by Michel Marty Breakdown of academic impact, for papers by G. Deplanque Breakdown of academic impact, for papers by Paul Stonelake Breakdown of academic impact, for papers by Yang Yao Breakdown of academic impact, for papers by Nobuyuki Mizunuma
Rankless by CCL
2026